Summit Therapeutics (SMMT) Return on Sales (2017 - 2024)
Historic Return on Sales for Summit Therapeutics (SMMT) over the last 10 years, with Q3 2025 value amounting to 3.5231079858176e16%.
- Summit Therapeutics' Return on Sales fell 3.523107985817601e20% to 3.5231079858176e16% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.5231079858176e16%, marking a year-over-year decrease of 3.523107985817601e20%. This contributed to the annual value of 111.75% for FY2022, which is 627700.0% down from last year.
- As of Q3 2025, Summit Therapeutics' Return on Sales stood at 3.5231079858176e16%, which was down 3.523107985817601e20% from 6.789001117696e16% recorded in Q2 2025.
- In the past 5 years, Summit Therapeutics' Return on Sales registered a high of 40.77% during Q1 2025, and its lowest value of 6.789001117696e16% during Q2 2025.
- Its 5-year average for Return on Sales is 8467202588701760.0%, with a median of 1.1% in 2021.
- As far as peak fluctuations go, Summit Therapeutics' Return on Sales skyrocketed by 2000000000bps in 2024, and later crashed by 2000000000bps in 2025.
- Over the past 5 years, Summit Therapeutics' Return on Sales (Quarter) stood at 1.1% in 2021, then tumbled by -15240bps to 169.27% in 2022, then tumbled by 2000000000bps to 3.359079111969545e16% in 2023, then soared by 100bps to 20.32% in 2024, then crashed by 2000000000bps to 3.5231079858176e16% in 2025.
- Its Return on Sales was 3.5231079858176e16% in Q3 2025, compared to 6.789001117696e16% in Q2 2025 and 40.77% in Q1 2025.